The journey of a drug-carrier in the body: an anatomo-physiological perspective.
By N. Bertrand, J. Leroux. Journal of Controlled Release, 2012
647 citations recorded by the source corpus.
Subfields: Biomaterials, Molecular Biology, Pharmaceutical Science
View Paper: https://www.semanticscholar.org/paper/9913a9c652816e413aa37068617b06317d66077f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomaterials
In Molecular Biology
- N. Bertrand
- N. Kamaly
- Xiaoyang Xu
- Jun Wu
- O. Farokhzad
- Alexandra R. Fernandes
- Pedro Viana Baptista
- Eric M. Pridgen
In Pharmaceutical Science
Citations in the corpus
- Interactions of nanomaterials and biological systems: implications to personalized nanomedicine (2012, background): “administered systemically, the proteins that adhere to their surface will greatly affect their circulation and biodistribution [22, 23].”
- Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination. (2016, background): “Mechanical properties (especially elasticity and deformability) of nanoparticles can also influence the efficiency of phagocytosis and blood circulation times [11].”
- Nano-Strategies to Fight Multidrug Resistant Bacteria—“A Battle of the Titans” (2018, methodology): “…assays and protocols to assist easy comparison of data originating from in vitro and in vivo studies, for the evaluation of theirmetabolism andmode of action (Duncan and Gaspar, 2011; Bertrand and Leroux, 2012; Beyth et al., 2015; Cordeiro et al., 2016; Rai M. et al., 2016; Zazo et al., 2016).”
- Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. (2014, background): “Nevertheless, this Phase 1 clinical trial did not focus on how the different MPS functions in the tumor correlate with the efficacy of the NPs.”
- Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems (2018, background): “Nanocarriers circulating in normal blood vessels do not easily leave the capillaries that perfuse tissues such as the kidney, lung and heart if they have a diameter range of 100–150 nm [18,22].”